BioStem Technologies, Inc. (BSEM)
3.92
+0.38
(+10.73%)
USD |
NASDAQ |
Aug 24, 16:00
3.86
-0.06
(-1.53%)
After-Hours: 20:00
BioStem Technologies Shareholders Equity (Quarterly) : 27.61M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 27.61M |
| March 31, 2026 | 31.87M |
| December 31, 2025 | 39.14M |
| September 30, 2025 | 50.02M |
| June 30, 2025 | 48.09M |
| March 31, 2025 | 47.52M |
| December 31, 2024 | 40.02M |
| September 30, 2024 | 22.83M |
| June 30, 2024 | 15.34M |
| March 31, 2024 | 6.642M |
| December 31, 2023 | -1.344M |
| September 30, 2023 | -3.526M |
| June 30, 2023 | -5.248M |
| March 31, 2023 | -4.565M |
| December 31, 2022 | -4.076M |
| September 30, 2022 | -3.188M |
| June 30, 2022 | -2.953M |
| March 31, 2022 | -3.063M |
| December 31, 2021 | -5.959M |
| September 30, 2021 | -5.791M |
| June 30, 2021 | -6.168M |
| March 31, 2021 | -5.949M |
| December 31, 2020 | -5.531M |
| September 30, 2020 | -5.479M |
| June 30, 2020 | -4.928M |
| Date | Value |
|---|---|
| March 31, 2020 | -4.400M |
| December 31, 2019 | |
| September 30, 2019 | |
| June 30, 2019 | |
| March 31, 2019 | |
| December 31, 2018 | -1.611M |
| September 30, 2018 | 0.5748M |
| June 30, 2018 | 0.2231M |
| March 31, 2018 | 1.160M |
| December 31, 2017 | 0.8431M |
| September 30, 2017 | 1.323M |
| June 30, 2017 | 3.653M |
| March 31, 2017 | 3.78M |
| December 31, 2016 | 0.4959M |
| September 30, 2016 | 0.827M |
| June 30, 2016 | 1.166M |
| March 31, 2016 | 1.176M |
| December 31, 2015 | |
| September 30, 2015 | |
| June 30, 2015 | |
| March 31, 2015 | |
| December 31, 2014 | |
| September 30, 2014 | |
| June 30, 2014 | 0.0524M |
| March 31, 2014 | 0.0542M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Filana Therapeutics, Inc. | 63.61M |
| CorMedix, Inc. | 460.83M |
| Eloxx Pharmaceuticals, Inc. | 46.42M |
| Cannabis Global, Inc. | -4.772M |
| Breakthrough Chemistry, Inc. | 0.8373M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 48.82M |
| Total Liabilities (Quarterly) | 21.20M |
| Debt to Equity Ratio | 0.0443 |
| Current Ratio | 0.9801 |
| Net Debt Paydown Yield | 1.05% |